For the Inventor, By the Inventor

Enter assignee name

Universite Paris Cité

USPTO Granted Patents = 55

CIPO Patents = 8

EPO Patents = 103

Forward Citations = 4

Loading Chart...

Loading Chart...

187 inventors (with patents filed for the assignee):

Mathieu Pernot (4 out of 27 patents)

Thomas Deffieux (3 out of 8 patents)

Frank Griscelli (3 out of 3 patents)

4. Annelise Bennaceur Griscelli (3 out of 3 patents)

5. Mickaël Tanter (3 out of 9 patents)

6. Olivier Hermine (2 out of 14 patents)

7. Didier Letourneur (2 out of 15 patents)

8. Arnold Munnich (2 out of 12 patents)

9. Vincent Petit (2 out of 6 patents)

10. Guido Kroemer (2 out of 16 patents)

11. Alessandro Siria (2 out of 7 patents)

12. Vincent Croquette (2 out of 15 patents)

13. Jean-Luc Battini (2 out of 5 patents)

14. Marc Sitbon (2 out of 7 patents)

15. Isabelle André (2 out of 3 patents)

Core Competencies:

Radiofrequency Signal Analysis

MR Elastography

Nucleic Acid Analysis

Sickle Cell Disease Treatment

Cancer Treatment Compositions

Microfluidic Devices

Terahertz Radiation Generation

Antibody Therapeutics

Biological Material Storage

T Cell Progenitor Generation

Optical Materials

Tissue Engineering Scaffolds

55 patents: Sort by Forward Citations

1. 12510416 - Reconstruction of a wavefront of a light beam containing optical vortices (2025-12-30),

2. 12508557 - Method for generating a flow in a microdrop and device for implementing the method (2025-12-30),

3. 12507963 - System for predicting a haemorrhagic stroke (2025-12-30),

4. 12487260 - Device for analyzing radiofrequency signal spectra (2025-12-02),

5. 12481009 - Motor for a MR elastography transducer (2025-11-25),

6. 12478964 - Device for the analysis of nucleic acid molecules (2025-11-25),

7. 12472164 - Masitinib for the treatment of sickle cell disease (2025-11-18),

8. 12427141 - BYL719 (alpelisib) for use in the treatment of PIK3CA-related overgrowth spectrum (PROS-CLOVES syndrome) (2025-09-30),

9. 12403193 - Allergen desensitization method (2025-09-02),

10. 12403110 - Methods and compositions for treating cancers (2025-09-02),

11. 12352761 - Use of ligands derived from receptor-binding domain of porcine endogenous retrovirus type B for diagnosing SMVT-related diseases (2025-07-08),

12. 12352055 - Pneumatic structure and associated production method (2025-07-08),

13. 12351634 - Use of cilengitide for ameliorating cardiac fibrosis occurring in response to myocardial infarction (2025-07-08),

14. 12343376 - Methods for inhibiting diazepam binding protein (2025-07-01),

15. 12318358 - Probenecid for use in treating epileptic diseases, disorders or conditions (2025-06-03),

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

55 Patents

#105 in Paris

#426 in France

#12,578 in the World

Universite Paris Cité

Forward Citations = 4

187 inventors:

Mathieu Pernot (4 out of 27 patents)

Thomas Deffieux (3 out of 8 patents)

Frank Griscelli (3 out of 3 patents)

4. Annelise Bennaceur Griscelli (3 out of 3 patents)

5. Mickaël Tanter (3 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…